daunorubicin has been researched along with levobunolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Hibino, S; Higuchi, T; Imamura, Y; Koga, T; Otagiri, M; Sugino, E | 1 |
2 other study(ies) available for daunorubicin and levobunolol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Inhibitory effect of drugs with a ketone group on reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney.
Topics: Acetohexamide; Alcohol Oxidoreductases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butyrophenones; Daunorubicin; Enzyme Inhibitors; Ketones; Kidney; Kinetics; Levobunolol; Molecular Structure; Oxidation-Reduction; Phenylpropionates; Propanolamines; Rabbits; Structure-Activity Relationship; Substrate Specificity | 1997 |